GlassScriptPhysician profile
Robert I Prince
NPI 1003871690
$1,785.74
in general payments reported to CMS, 2019-2025
14 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $12.40 · 2021: $134 · 2022: $241 · 2023: $186 · 2024: $383 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $953.05 | 2019-2025 | Eterna, Proclaim |
| Abbvie INC. | $221.57 | 2023-2025 | |
| Nevro Corp. | $149.31 | 2022 | |
| Boston Scientific Corporation | $100.75 | 2024-2025 | Intracept |
| Si-Bone, INC. | $89.37 | 2022-2025 | |
| Vertex Pharmaceuticals Incorporated | $56.88 | 2025 | |
| Depuy Synthes Sales INC. | $46.47 | 2021 | |
| Relievant Medsystems, INC. | $34.31 | 2023 | Intracept |
| Lilly USA, LLC | $32.58 | 2023-2024 | Emgality |
| Medtronic, INC. | $29.43 | 2021-2024 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $23.67 | 2025 | Sprint Pns System |
| Mml US, INC. | $21.31 | 2025 | Reactiv8 |
| Vertos Medical, INC. | $14.64 | 2023 | Mild Device Kit |
| Pfizer INC. | $12.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Prince listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.